ArticleAmerican journal of translational research2023
Durable responses to TAS-102 plus bevacizumab and TACE in salvage-line treatment of KRAS-mutated and MSS metastatic colorectal cancer: a case report.
Wensi Zhao et al.PubMed ↗Full text ↗
No numbers read from the abstract.